4 Revisiting immunotherapy for prostate cancer 4.1 Advancing immune checkpoint blockade therapy with peptide-based innovations Immunotherapy for solid tumors primarily leverages inhibitors targeting programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA-4), collectively known as ICB (Sun et al., 2023a)
Cell 179:312339
Cancer Res 82:CT108CT108 Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P et al (2020) Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
Follow-Up And Support Along with a diet and exercise plan, patients will have access to 24/7 on-call doctors to offer additional support to all patients, including those who choose our semaglutide online program near Milwaukee
Many also fail to document their process thoroughly, making it difficult to troubleshoot or reproduce results
When in doubt, discard and reconstitute a fresh vial